ProCE Banner Events


Hot Topics in Neurology Summit

Join us for this FREE live, virtual summit Saturday, October 21, 2023, and earn up to 5 CME/CE credits. CCO’s Hot Topics in Neurology brings together the world’s leading experts for a discussion on the latest advances in treatment options for patients with neurological disorders. 

Register now for this state-of-the-art live virtual summit! 

Pharmacists: 5.00 contact hours (0.5 CEUs)

Registered Nurses: 5.00 Nursing contact hours, including 5.00 hours of pharmacotherapy credit

Physicians: maximum of 5.00 AMA PRA Category 1 Credits

Physician Assistants/Physician Associates: 5.00 AAPA Category 1 CME credits

This event has expired. No longer available for credits.

Credits Available


Who Should Attend

This program is intended for a multidisciplinary audience of neurologists, psychiatrists, primary care physicians, nurses, nurse practitioners, physician associates/physician assistants, pharmacists, and other members of the healthcare team involved in the management of neurology patients.

Time and location

Saturday, October 21, 2023

10:00 AM - 5:00 PM Eastern Time (ET)


Jacci Bainbridge, PharmD, FCCP, MSCS, FAES

Professor and Vice Chair Research
Skaggs School of Pharmacy and Pharmaceutical Sciences
Department of Clinical Pharmacy and Neurology
University of Colorado
Anschutz Medical Campus
Aurora, Colorado

Kathryn Adamiak Davis, MD, MSc, FAES, FANA

Associate Professor of Neurology
University of Pennsylvania
Penn Epilepsy Center
Associate Director
Center for Neuroengineering and Therapeutics
Philadelphia, Pennsylvania

Theodore D. Satterthwaite, MD

McLure Associate Professor of Psychiatry
Director, Penn Lifespan Informatics and Neuroimaging Center (PennLINC)
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania

Katherine T. Hamilton, MD

Assistant Professor of Neurology
Georgetown Headache Center
Medstar Georgetown University
Washington, DC

Vanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN

Senior Director of Nursing, Palliative Care
Psychosocial Oncology and Palliative Care
Boston, Massachusetts

Stuart Isaacson, MD

Clinical Associate Professor of Neurology
FIU Herbert Wertheim College of Medicine
Miami, Florida
Parkinsons Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida

Victor W. Sung, MD

Department of Neurology
Division of Movement Disorders
Clinic Director
Huntington's Disease Clinic/HDSA Center of Excellence
University of Alabama at Birmingham
Birmingham, Alabama


Saturday, October 21, 2023 - Eastern Time Zone

10:00 AM – 10:05 AM: Opening Remarks

10:05 AM – 11:05 AM: CME session 1 – The Future of AI in Neurology: A Fireside Chat – Presented by: Kathryn Davis, MD, and Theodore Satterthwaite, MD

  • Use of technology and artificial intelligence is becoming more prevalent to aid in diagnosis and treatment of neurological diseases. This session will provide insights from experts in technology and AI in neurology to discuss the evolution of this field as well as challenges with implementation.

11:05 AM – 11:15 AM: Break

11:15 AM – 12:15 PM: Moving Forward: An Informed Approach to the Diagnosis and Treatment of Tardive Dyskinesia Presented by: Stuart Isaacson, MD Non-CME Educational Talk - Sponsored by Neurocrine Biosciences, Inc.

  • This program provides a straightforward overview of tardive dyskinesia, including its symptoms, prevalence, risk factors, and impact.  Faculty will share the clinical data for an FDA-approved treatment option for adults with tardive dyskinesia.  In addition, participants will have the opportunity to examine cases of real patients with tardive dyskinesia by observing videos of the patients before and after treatment.  This program is non-CME educational content sponsored by Neurocrine Biosciences.

12:15 PM – 12:25 PMBreak

12:25 PM – 1:25 PM: CME session 2 Advances in Multiple Sclerosis Care: Diagnosis and Treatment Presented by: Jacci Bainbridge, PharmD

  • Despite recent advances in MS, diagnostic delays leading to treatment delays continues to be a problem. This session will discuss diagnostic criteria and advances in DMTs, including patient characteristics that determine appropriateness and the latest evidence for treatment in MS.

1:25 PM – 1:35 PM: Wellness Video Break

1:35 PM – 2:35 PM: CME session 3 – The Changing Landscape of Huntington's Disease TreatmentPresented by: Victor Sung, MD

  • This multifaceted educational session will explore the impact of chorea on individuals with HD, the importance of identification and treatment, and provide an update on treatment options. 

2:35 PM – 2:45 PM Break

2:45 PM – 3:45 PM: CME session 4 – Navigating Treatment and the Transition Journey to Adulthood for Patients With SMA Presented by: Vanessa Battista, DNP 

  • The emergence of disease-modifying therapies (DMTs) in recent years has transformed the treatment paradigm for SMA, often extending life expectancy. This session explores the implications of DMTs on the current treatment paradigm for SMA and the need for transition plans for patients entering adulthood.

3:45 PM – 3:55 PM Wellness Video Break

3:55 PM – 4:55 PM: CME session 5 – The Power of Prevention: CGRP-Targeted Agents for Migraine Presented by: Katherine Hamilton, MD

  • This enlightening session on migraine prevention will address the burden on patients and the healthcare system, the importance of proper diagnosis and early intervention for those who qualify for preventive care, and assess the latest evidence for CGRP-targeted therapies.

 4:55 PM – 5:00 PM: Closing Remarks


Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners in the diagnosis and management of neurological disorders utilizing the most updated evidence and new and emerging therapies.

Target Audience
This program is intended for a multidisciplinary audience of neurologists, psychiatrists, primary care physicians, nurses, nurse practitioners, physician associates/physician assistants, pharmacists, and other members of the healthcare team involved in the management of neurology patients.

Learning Objectives
Upon completion of this activity, participants should be able to:

  •    Assess the latest advances in treatment options for patients with neurological disorders 
  •    Develop individualized treatment strategies for optimal outcomes in patients with neurological disorders 
  •    Identify best practices for improving patient care


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity will be 5.0 contact hours, including 5.0 hours of pharmacology credit.

Continuing Pharmacy Education

CCO designates this continuing education activity for 5.0 contact hours (0.5 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - Specific to each topic

Type of Activity: Specific to each topic

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate/Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


Provided by Clinical Care Options, LLC

Supported by an educational grant from Neurocrine Biosciences, Inc.

Contact Information

Contact Clinical Care Options

For customer support please click here.

Mailing Address:

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.